Monod Bio, Inc. reported raising $6 Million in an initial SEC Form D filing, from an offering of $6.1 Million
Amount Raised
$6 Million
Round Type
Venture
SeattleBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Monod Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Kula Bio raised $50M on January 28, 2022.
- Crossfire Medical Inc raised $3M (Seed) on January 27, 2022.
- Kula Bio raised $50M (Series A) on January 27, 2022.
- Septerna raised $100M (Series A) on January 27, 2022.
- NextRNA Therapeutics raised $23M on January 27, 2022.
- Metagenomi Therapeutics, Inc. raised $175M (Series B) on January 26, 2022.
Who to call at Monod Bio, Inc., and when
A new round usually means Monod Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Monod Bio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Monod Bio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Monod Bio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Monod Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Monod Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.